Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Pfizer Inc (PFE)  
$25.40 0.14 (0.55%) as of 4:30 Fri 4/26


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 5,560,000,000
Market Cap: 141.22(B)
Last Volume: 46,511,071 Avg Vol: 30,315,820
52 Week Range: $25.26 - $40.28
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     DOW JONES COMPOSITE
    DOW JONES INDUSTRIAL AVERAGE     NYSE COMPOSITE
    S&P 100     S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 6.5
Insider 3/6 Months : 7.1
Guru Rank Number :  710
Guru Rank Value     : 1.7
Guru Occurances    : 3

 

            6 Months   1 Year   2 Year  
 
Company Profile   Pfizer is a research-based biopharmaceutical company. Co. is engaged in the discovering, developing, manufacturing, marketing, sales and distribution of biopharmaceutical products. Co.'s business includes: internal medicine, which includes cardiovascular metabolic and pain products; oncology, which includes products in biologics, small molecules, immunotherapies, and biosimilars for cancers; hospital, which includes Co.'s portfolio of sterile injectable and anti-infective medicines, as well as Pfizer CentreOne; vaccines, which includes vaccines brands in pneumococcal disease, meningococcal disease, tick-borne encephalitis and COVID-19; inflammation and immunology; and rare disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 3,000 5,000 5,000
Total Buy Value $0 $79,401 $156,406 $156,406
Total People Bought 0 1 1 1
Total Buy Transactions 0 1 3 3
Total Shares Sold 0 0 0 154,621
Total Sell Value $0 $0 $0 $7,584,472
Total People Sold 0 0 0 5
Total Sell Transactions 0 0 0 7
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 1390
  Page 3 of 56  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sahni Payal Executive Vice President   •       •      –    2023-02-25 4 OE $22.89 $204,202 D/D 8,921 30,127     -
   Johnson Rady A Executive Vice President   •       •      –    2023-02-25 4 D $41.75 $978,696 D/D (22,836) 93,637     -
   Johnson Rady A Executive Vice President   •       •      –    2023-02-25 4 OE $22.89 $770,340 D/D 33,654 116,473     -
   Susman Sally Executive Vice President   •       •      –    2023-02-25 4 D $41.75 $2,345,588 D/D (54,868) 154,311     -
   Susman Sally Executive Vice President   •       •      –    2023-02-25 4 OE $22.89 $1,670,604 D/D 72,984 209,179     -
   Damico Jennifer B. SVP & Controller   •       •      –    2023-02-24 4 D $41.75 $15,030 D/D (360) 16,383     -
   Damico Jennifer B. SVP & Controller   •       •      –    2023-02-23 4 A $0.00 $0 D/D 3,103 16,743     -
   Damico Jennifer B. SVP & Controller   •       •      –    2023-02-22 4 D $42.38 $345,069 D/D (7,944) 13,640     -
   Damico Jennifer B. SVP & Controller   •       •      –    2023-02-22 4 OE $30.17 $315,458 D/D 10,456 21,584     -
   Hwang Angela President, Global Biopharmaceu   •       •      –    2023-02-22 4 D $42.38 $1,857,954 D/D (42,759) 24,268     -
   Hwang Angela President, Global Biopharmaceu   •       •      –    2023-02-22 4 OE $30.17 $1,720,655 D/D 57,032 67,027     -
   Johnson Rady A Executive Vice President   •       •      –    2023-02-22 4 D $42.38 $1,031,333 D/D (23,737) 82,819     -
   Johnson Rady A Executive Vice President   •       •      –    2023-02-22 4 OE $30.17 $952,105 D/D 31,558 106,556     -
   Sahni Payal Executive Vice President   •       •      –    2023-02-22 4 D $42.38 $498,109 D/D (11,465) 21,206     -
   Sahni Payal Executive Vice President   •       •      –    2023-02-22 4 OE $30.17 $458,856 D/D 15,209 32,671     -
   Bourla Albert Chairman & CEO   •       •      –    2023-02-22 4 D $42.38 $2,627,306 D/D (61,994) 352,477     -
   Susman Sally Executive Vice President   •       •      –    2023-02-22 4 D $42.38 $2,574,153 D/D (59,298) 136,195     -
   Susman Sally Executive Vice President   •       •      –    2023-02-22 4 OE $30.17 $2,294,217 D/D 76,043 195,493     -
   Mcdermott Michael Executive Vice President   •       •      –    2023-02-22 4 D $42.38 $436,019 D/D (10,036) 78,921     -
   Mcdermott Michael Executive Vice President   •       •      –    2023-02-22 4 OE $30.17 $401,472 D/D 13,307 88,957     -
   Dolsten Mikael President R&D   •       •      –    2023-02-22 4 D $42.38 $1,381,249 D/D (32,592) 391,223     -
   Lankler Douglas M Executive Vice President   •       •      –    2023-02-22 4 D $42.38 $842,430 D/D (19,878) 161,535     -
   Bourla Albert Chairman & CEO   •       •      –    2022-12-16 4 OE $22.89 $6,058,580 D/D 222,328 411,890     -
   Lankler Douglas M Executive Vice President   •       •      –    2022-12-14 4 OE $22.89 $2,672,548 D/D 101,658 180,461     -
   Dolsten Mikael President R&D   •       •      –    2022-11-07 4 OE $30.17 $2,627,260 D/D 79,108 420,007     -
  1390 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 56
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us